|
|
 |
|
News/Event Item
Cervical Cancer Advances Give Hope to Poor
Aug. 28, 2008
By Michael Kahn
New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers said.
Experts who presented their findings at a conference in Geneva said the vaccines against the disease could be cost effective but subsidies or new prices would be needed for developing countries to afford the medicines.
"Efforts are needed now to adapt the current price of the vaccines so they meet what individual countries can afford," Francesco Xavier Bosch of the Catalan Institute of Oncology in Barcelona told the World Cancer Congress.
© 2008 Reuters
For full article, visit:
http://www.reuters.com/article/marketsNews/idUSLS1404220080828
category: Member Organization News : General Health News
contributed by Liza Nanni on 5 September 2008
Global :
|
|
